Cladis Investment Advisory »

Vertex Pharmaceuticals Incorporated shares owned by Cladis Investment Advisory

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Cladis Investment Advisory from 13F filings

Historical chart of Cladis Investment Advisory investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Cladis Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Cladis Investment Advisory

Quarter filed Position value Share count Share price at filing
2025-12-31 $246k 542 453.36

More positions owned by Cladis Investment Advisory

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
Ge Aerospace Com New (GE)
Invesco Qqq Tr Unit Ser Q (QQQ)
Select Sector Spdr Tr Technology (XLK)
International Business Machines (IBM)
Ge Vernova (GEV)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
First Intst Bancsystem Com Cl A (FIBK)
Costco Wholesale Corporation (COST)
Caterpillar (CAT)
Exxon Mobil Corporation (XOM)

View all positions for Cladis Investment Advisory

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Victory Capital Management
FMR
Jennison Associates
Norges Bank Investment Management

View all funds holding Vertex Pharmaceuticals Incorporated